These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 952292)

  • 21. Thrombin generation and formation of thrombin-antithrombin III complexes in congenital antithrombin III deficiency.
    Boyer C; Wolf M; Lavergne JM; Larrieu MJ
    Thromb Res; 1980 Oct; 20(2):207-18. PubMed ID: 7209877
    [No Abstract]   [Full Text] [Related]  

  • 22. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of platelet function. Correlation with platelet volume.
    Karpatkin S; Khan Q; Freedman M
    Am J Med; 1978 Apr; 64(4):542-6. PubMed ID: 347931
    [No Abstract]   [Full Text] [Related]  

  • 24. Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex.
    Polley MJ; Nachman RL
    J Exp Med; 1979 Sep; 150(3):633-45. PubMed ID: 479764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Class III PI3K Positively Regulates Platelet Activation and Thrombosis via PI(3)P-Directed Function of NADPH Oxidase.
    Liu Y; Hu M; Luo D; Yue M; Wang S; Chen X; Zhou Y; Wang Y; Cai Y; Hu X; Ke Y; Yang Z; Hu H
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2075-2086. PubMed ID: 28882875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of antithrombin III procedures.
    Rose M; Wideman CS; Evatt BL; Haff E
    Clin Lab Haematol; 1983; 5(2):185-95. PubMed ID: 6883970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombosis induced by homocysteine does not depend on platelet aggregation or heparin cofactor's antithrombin activity].
    Zhang L; Zhang G
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):309-12, 340. PubMed ID: 12080632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood coagulation and platelet profiles in persistent post-splenectomy thrombocytosis. The relationship to thromboembolism.
    Visudhiphan S; Ketsa-Ard K; Piankijagum A; Tumliang S
    Biomed Pharmacother; 1985; 39(6):264-71. PubMed ID: 4084660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. INACTIVATION OF PURIFIED AUTOPROTHROMBIN I WITH ANTITHROMBIN.
    SEEGERS WH; SCHROEER H; KAGAMI M
    Can J Biochem; 1964 Oct; 42():1425-35. PubMed ID: 14240727
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 31. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
    Zucker MB; Mauss EA
    Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human platelet factor 4: subcellular localization and characteristics of release from intact platelets.
    Ryo R; Proffitt RT; Deuel TF
    Thromb Res; 1980 Mar; 17(5):629-44. PubMed ID: 7385099
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom.
    Huang TF; Wu YJ; Ouyang C
    Biochim Biophys Acta; 1987 Sep; 925(3):248-57. PubMed ID: 3620499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombin activity and central venous catheter-associated thrombosis in critically ill children at high risk of bleeding.
    Quinn T; Cholette JM; Pinto MG; Schreiber H; Madden MA; Bennett E; Kolmar A; Poole A; Silva CT; Ehrlich L; Navarro OM; Faustino EVS;
    J Thromb Haemost; 2024 Jan; 22(1):213-224. PubMed ID: 37797693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombin.
    Hepner M; Karlaftis V
    Methods Mol Biol; 2013; 992():355-64. PubMed ID: 23546728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood tests for the diagnosis of venous and arterial thrombosis.
    Hirsh J
    Blood; 1981 Jan; 57(1):1-8. PubMed ID: 7004530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protease and cyclooxygenase inhibitors synergistically prevent activation of human platelets.
    Ruggiero M; Lapetina EG
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3456-9. PubMed ID: 3458190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clq inhibition of the interaction of collagen with human platelets.
    Cazenave JP; Assimeh SN; Painter RH; Pachham MA; Mustard JF
    J Immunol; 1976 Jan; 116(1):162-3. PubMed ID: 1245737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.